Joanne Rasschaert

Prof. Joanne Rasschaert


Research Focus & Metrics

Academic Career Length

24Years (2003-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 October 2005 in Journal of Biological Chemistry
Verified
Journal Article
Open access
PDF file
JRJoanne Rasschaert
Joanne Rasschaert
LLLaurence Ladrière
Laurence Ladrière
MUMaryse Urbain
Maryse Urbain
ZDZeynep Dogusan
Zeynep Dogusan
BKBitty Katabua
Bitty Katabua
DEDecio L. Eizirik
Decio L. Eizirik
Viral infections and local production of cytokines probably contribute to the pathogenesis of Type 1 diabetes. The viral replicative intermediate double-stranded RNA (dsRNA, tested in the form of polyinosinic-polycytidylic acid, PIC), in combination with the cytokine interferon-γ (IFN-γ), triggers β-cell apoptosis. We have previously observed by microarray analysis that PIC induces expression of several mRNAs encoding for genes downstream of Toll-like receptor 3 (TLR3) signaling pathway. In this report, we show that exposure of β-cells to dsRNA in combination with IFN-α, -β, or -γ significantly increases apoptosis. Moreover, dsRNA induces TLR3 mRNA expression and activates NF-κB and the IFN-β promoter in a TRIF-dependent manner. dsRNA also induces an early (1 h) and sustained increase in IFN-β mRNA expression, and blocking IFN-β with a specific antibody partially prevents PIC plus IFN-γ-induced β-cell death. On the other hand, dsRNA plus IFN-γ does not induce apoptosis in INS-1E cells, and expression of TLR3 and type I IFNs mRNAs is not detected in these cells. Of note, disruption of the STAT-1 signaling pathway protects β-cells against dsRNA plus IFN-γ-induced β-cell apoptosis. This study suggests that dsRNA plus IFN-γ triggers β-cell apoptosis by two complementary pathways, namely TLR3-TRIF-NF-κB and STAT-1.

15 January 2009 in BMC Medical Genomics
Verified
Journal Article
Open access
PDF file
BKBurak Kutlu
Burak Kutlu
DBDavid Burdick
David Burdick
DBDavid Baxter
David Baxter
JRJoanne Rasschaert
Joanne Rasschaert
DFDaisy Flamez
Daisy Flamez
LHLeroy Hood
Leroy Hood
Gene expression patterns provide a detailed view of cellular functions. Comparison of profiles in disease vs normal conditions provides insights into the processes underlying disease progression. However, availability and integration of public gene expression datasets remains a major challenge. The aim of the present study was to explore the transcriptome of pancreatic islets and, based on this information, to prepare a comprehensive and open access inventory of insulin-producing beta cell gene expression, the Beta Cell Gene Atlas (BCGA). We performed Massively Parallel Signature Sequencing (MPSS) analysis of human pancreatic islet samples and microarray analyses of purified rat beta cells, alpha cells and INS-1 cells, and compared the information with available array data in the literature. MPSS analysis detected around 7600 mRNA transcripts, of which around a third were of low abundance. We identified 2000 and 1400 transcripts that are enriched/depleted in beta cells compared to alpha cells and INS-1 cells, respectively. Microarray analysis identified around 200 transcription factors that are differentially expressed in either beta or alpha cells. We reanalyzed publicly available gene expression data and integrated these results with the new data from this study to build the BCGA. The BCGA contains basal (untreated conditions) gene expression level estimates in beta cells as well as in different cell types in human, rat and mouse pancreas. Hierarchical clustering of expression profile estimates classify cell types based on species while beta cells were clustered together. Our gene atlas is a valuable source for detailed information on the gene expression distribution in beta cells and pancreatic islets along with insulin producing cell lines. The BCGA tool, as well as the data and code used to generate the Atlas are available at the T1Dbase website (T1DBase.org).

1 February 2018 in Bone
Verified
Journal Article
Closed access
VGValérie Gangji
Valérie Gangji
MSMuhammad S Soyfoo
Muhammad S Soyfoo
AHAudrey Heuschling
Audrey Heuschling
VAViolaine Afzali
Violaine Afzali
RMRodrigo Moreno-Reyes
Rodrigo Moreno-Reyes
JHJean-Philippe Hauzeur
Jean-Philippe Hauzeur

5 November 2003 in Diabetologia
Verified
Journal Article
Closed access
PDF file
JRJoanne Rasschaert
Joanne Rasschaert
DLD. Liu
D. Liu
BKB. Kutlu
B. Kutlu
ACAlessandra Kupper Cardozo
Alessandra Kupper Cardozo
DED. L. Eizirik
D. L. Eizirik
TØT. F. Ørntoft
T. F. Ørntoft

2 September 2014 in Stem Cells
Verified
Journal Article
Open access
PDF file
JBJessica L. Berlier
Jessica L. Berlier
SRSabrina Rigutto
Sabrina Rigutto
AVAntoine Dalla Valle
Antoine Dalla Valle
JLJessica Lechanteur
Jessica Lechanteur
MSMuhammad S. Soyfoo
Muhammad S. Soyfoo
JRJoanne Rasschaert
Joanne Rasschaert
Human mesenchymal stem cells (hMSC) are multipotent cells derived from various sources including adipose and placental tissues as well as bone marrow. Owing to their regenerative and immunomodulatory properties, their use as a potential therapeutic tool is being extensively tested. However, one of the major hurdles in using cell-based therapy is the use of fetal bovine serum that can trigger immune responses, viral and prion diseases. The development of a culture medium devoid of serum while preserving cell viability is therefore a major challenge. In this study, we demonstrated that adenosine triphosphate (ATP) restrained serum deprivation-induced cell death in hMSC by preventing caspases 3/7 activation and modulating ERK1/2 and p38 MAPK signaling pathways. We also showed that serum deprivation conditions triggered dephosphorylation of the proapoptotic protein Bad leading to cell death. Adjunction of ATP restored the phosphorylation state of Bad. Furthermore, ATP significantly modulated the expression of proapoptopic and antiapoptotic genes, in favor of an antiapoptotic profile expression. Finally, we established that hMSC released a high amount of ATP in the extracellular medium when cultured in a serum-free medium. Collectively, our results demonstrate that ATP favors hMSC viability in serum deprivation conditions. Moreover, they shed light on the cardinal role of the MAPK pathways, ERK1/2 and p38 MAPK, in promoting hMSC survival. Stem Cells 2015;33:211–218

9 August 2015 in Stem Cell Reviews and Reports
Verified
Journal Article
Closed access
PDF file
JBJ. L. Berlier
J. L. Berlier
IKI. Kharroubi
I. Kharroubi
JZJ Zhang
J Zhang
AVA. Dalla Valle
A. Dalla Valle
SRS. Rigutto
S. Rigutto
JRJoanne Rasschaert
Joanne Rasschaert